Mycophenolate Mofetil Tablets Ip 500 Mg Specific Drug

Immutil tablets IP is indicated for the prophylaxis of organ rejection in recipients of allogeneic renal, cardiac or hepatic transplants. Immutil (mycophenolate mofetil) is indicated for use in kidney transplant patients to prevent rejection. Immutil tablets are an immuno-suppressant used to stop your body from rejecting an organ transplant. Immutil is a modified form of an antibiotic called mycophenolate and is broken down into an active compound in your body that stops the immune system from working properly. This can help prevent problems such as rejection of your new kidney by your own body Immutil is indicated for treatment of adult and pediatric renal transplant recipients to reduce the incidence of acute rejection